Dashboard

Beam Therapeutics Inc.

BEAMNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$2.6B

Price$25.1052w $16.01 – $37.92

Conviction3/ 5

Revenue (TTM)$164M

Revenue growth YoY+158.0%

P/E (trailing)—

Gross margin-39.2%

Operating margin-226.6%

Net margin-39.7%

52w price change+55.0%

Next earningsAug 4, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

Jul 2
Ownership changeSEC
Form 4 insider ownership change filing filed 2026-07-02
Jul 1
Ownership changeSEC
Form 4 insider beneficial ownership report filed.
Jun 29
Ownership changeSEC
Form 4 insider ownership change filing.
Jun 22
Ownership changeSEC
Form 4 insider ownership change filing dated 2026-06-22
Jun 8
OtherSEC
8-K filed disclosing results of matters submitted to shareholder vote (Item 5.07).
Jun 5
Ownership changeSEC
Form 4 insider transaction filing by Beam Therapeutics.
Jun 5
Ownership changeSEC
Form 4 insider transaction filing for Beam Therapeutics Inc.
Jun 5
Ownership changeSEC
Form 4 insider transaction filing
Jun 5
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jun 5
Ownership changeSEC
SEC Form 4 filing reporting change in beneficial ownership.
Jun 5
Ownership changeSEC
Form 4 filing for change in beneficial ownership by insider at Beam Therapeutics.
May 7
Financial resultsSEC
Beam Therapeutics filed 8-K (items 2.02,9.01) disclosing financial results.

Not financial advice — research and opinion only. Disclosures